2c6n
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Structure of human somatic angiontensin-I converting enzyme N domain with lisinopril== | ==Structure of human somatic angiontensin-I converting enzyme N domain with lisinopril== | ||
- | <StructureSection load='2c6n' size='340' side='right' caption='[[2c6n]], [[Resolution|resolution]] 3.00Å' scene=''> | + | <StructureSection load='2c6n' size='340' side='right'caption='[[2c6n]], [[Resolution|resolution]] 3.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2c6n]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2C6N OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[2c6n]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2C6N OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=2C6N FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=LPR:[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE'>LPR</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACT:ACETATE+ION'>ACT</scene>, <scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=LPR:[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE'>LPR</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2c6f|2c6f]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2c6f|2c6f]]</td></tr> | ||
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidyl-dipeptidase_A Peptidyl-dipeptidase A], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.15.1 3.4.15.1] </span></td></tr> | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Peptidyl-dipeptidase_A Peptidyl-dipeptidase A], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.15.1 3.4.15.1] </span></td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=2c6n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2c6n OCA], [http://pdbe.org/2c6n PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=2c6n RCSB], [http://www.ebi.ac.uk/pdbsum/2c6n PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=2c6n ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 35: | Line 35: | ||
==See Also== | ==See Also== | ||
*[[ACE Inhibitor Lisinopril|ACE Inhibitor Lisinopril]] | *[[ACE Inhibitor Lisinopril|ACE Inhibitor Lisinopril]] | ||
- | *[[Angiotensin-Converting Enzyme|Angiotensin-Converting Enzyme]] | + | *[[Angiotensin-Converting Enzyme 3D structures|Angiotensin-Converting Enzyme 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
Line 41: | Line 41: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Peptidyl-dipeptidase A]] | [[Category: Peptidyl-dipeptidase A]] | ||
[[Category: Acharya, K R]] | [[Category: Acharya, K R]] |
Revision as of 07:28, 29 April 2020
Structure of human somatic angiontensin-I converting enzyme N domain with lisinopril
|
Categories: Human | Large Structures | Peptidyl-dipeptidase A | Acharya, K R | Corradi, H R | Nichinda, A | Schwager, S L.U | Sturrock, E D | Angiotensin | Angiotensin-i converting enzyme | Carboxypeptidase | Glycoprotein | Hydrolase | Hydrolase-hydrolase inhibitor complex | Lisinopril | Metal-binding | Metalloprotease | N domain | Phosphorylation | Protease | Transmembrane | Zinc metallopeptidase